Search

everythinglearnresearchcommunity

for

Search:↓

The study found that severe alopecia areata affects any age, treatments often give temporary results, and some factors predict worse outcomes.

Intralesional triamcinolone is the most effective treatment for alopecia areata, followed by excimer light therapy, and then topical minoxidil. The scalp responds better to treatment than the beard area.

The document concludes that doctors should recognize congenital triangular alopecia to avoid unnecessary treatments, as it does not respond to steroids like alopecia areata does.

Higher RBP4 levels found in people with two types of hair loss.

The document concludes that more research is needed to understand and treat Beard Alopecia Areata due to limited current knowledge and evidence.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

PRP did not significantly regrow hair in alopecia areata totalis patients.

Platelet-rich plasma and microneedling could potentially help hair growth in people with alopecia areata, but more research is needed.

The guidelines offer updated treatment recommendations for alopecia areata in Korea using topical and device-based methods.

Intralesional corticosteroids are the best for limited alopecia areata, oral steroids are less effective, and PRP is safe and promising, especially for children and severe cases.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

There is no significant link between metabolic syndrome and alopecia areata.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

Platelet-rich plasma and microneedling could potentially help hair regrowth in alopecia areata patients, but more research is needed.

Hair loss in three Southeast Asian women with kidney failure may be linked to their anemia treatment with erythropoietin.

Alopecia areata causes sudden hair loss, has genetic links, and can be managed but not cured.

Oxidative stress is important in causing alopecia areata.

Higher IL-21 levels may help predict alopecia areata activity.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

The 2003 guidelines suggest that while some treatments can regrow hair in alopecia areata, none alter the disease's progression, and wigs may be the best option for extensive hair loss.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

Some treatments, like corticosteroids and sensitizing agents, can help with alopecia areata, but more high-quality research is needed.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

The combination of cyclosporine and PUVA might help treat severe alopecia areata.

Alopecia areata involves specific T-cells, unlike androgenetic alopecia.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

Using a strong allergy medicine too often on the scalp can cause swelling and inflammation.